Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?

22 May 2015

Abstract excerpt

γδ T cell-based immunotherapeutic strategies in cancer patients are as yet of limited success. Drugs targeting epigenetic mechanisms including histone acetylation and DNA methylation trigger cell death in tumor cells but in addition have immunomodulatory activity. Here, we discuss the potential benefit of combining both strategies in cancer immunotherapy.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to CAR-T cell therapy research
Share to Immune Cell Function and Interaction

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26155411
DOI: 10.1080/2162402x.2015.1006088

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?PMID 26155411Read ↗

Epigenetic modulation in cancer immunotherapySemantic proximity Read ↗

γδ T cells in cancer immunotherapy.Semantic proximity Read ↗

Targeting γδ T Lymphocytes for Cancer Immunotherapy: From Novel Mechanistic Insight to Clinical ApplicationSemantic proximity Read ↗

Role of γδ T Cells in Cancer Progression and Therapy.Semantic proximity Read ↗

Molecular Pathways: At the Crossroads of Cancer Epigenetics and Immunotherapy.Semantic proximity Read ↗

Enhancing anti-tumor immune responses through combination therapies: epigenetic drugs and immune checkpoint inhibitorsSemantic proximity Read ↗

Enhancing the Anticancer Efficacy of Immunotherapy through Combination with Histone Modification InhibitorsSemantic proximity Read ↗

Epigenome-Driven Strategies for Personalized Cancer ImmunotherapySemantic proximity Read ↗

The Cancer Epigenome: Exploiting Its Vulnerabilities for Immunotherapy.Semantic proximity Read ↗

The Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor EfficacySemantic proximity Read ↗

Combining DNA damaging therapeutics with immunotherapy: more haste, less speedSemantic proximity Read ↗

Epigenetic modulation of solid tumors as a novel approach for cancer immunotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.